Globus Medical, Inc. Overview
Pro stress-test →Globus Medical is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, focused on designing, developing, and commercializing products that enable surgeons to promote healing in patients with musculoskeletal disorders. The company has established itself as a dominant player in spine surgery, orthopedic trauma, and robotic-assisted surgical technologies.
Strategic Profile
Pro stress-test →The company offers enabling technologies including imaging, navigation, and robotics (INR) solutions for assisted surgery, notably the ExcelsiusGPS platform, a robotic guidance system for minimally invasive and open procedures. In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion, significantly expanding its portfolio and market reach. The company operates with an aggressive acquisition strategy combined with organic product innovation across implants, instruments, and software platforms.
Competitive Landscape
Pro stress-test →Top competitors include Integra LifeSciences, CooperSurgical, Avalign Technologies, and Zimmer Biomet. Globus Medical differentiates through its integrated portfolio spanning implants, instruments, biologics, and advanced robotic-assisted surgery solutions, competing effectively in the high-value spine and orthopedic trauma segments. The company's focus on enabling technologies and surgical innovation creates competitive moats against traditional device manufacturers.
Industry Context
Globus Medical, Inc. operates in Medical Devices - Orthopedic/Spine Surgery.
Key facts
Founded: 2003 · Headquarters: Audubon, US · Employees: 5,300 · Revenue: $2.88B · Market cap: $11.9B